Clinical Trial Update: Evaluation of the Effect of Metformin on Metastatic Breast Cancer as Adjuvant Treatment [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating metformin as adjuvant therapy for metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Hager salah el din | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED